Palantir Technologies Inc.

PLTR

CIK 0001321655 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$1.41B
↑+70.0% +$579Mvs FY2024 (Q4)
Operating Income
$575M
↑+5110.5% +$564Mvs FY2024 (Q4)
Net Income
$566M
↑+7501.4% +$558Mvs FY2024 (Q4)
Gross Profit
$1.19B
↑+82.4% +$538Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
86/100
  • Profitability
    88ROIC 22.5% (10% = solid, 20%+ = moat)
  • Liquidity
    100Current Ratio 7.11 (above 1.5 = solid)
  • Leverage
    100D/E 0.00 (under 0.5 = conservative)
  • Efficiency
    30Asset Turnover 0.59x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +70.0% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin 40.9% · trend +18.9pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project PLTR's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

25%

Trailing 3-yr CAGR was 125.3%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$27.31
Total enterprise IV
$70.06B
Diluted shares
2.57B
Terminal PV
$54.40B (78% of total)
Year-5 FCF
$6.41B
YearProjected FCFDiscounted PV
+1$2.63B$2.39B
+2$3.28B$2.71B
+3$4.10B$3.08B
+4$5.13B$3.50B
+5$6.41B$3.98B
Terminal$87.61B$54.40B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$34M
investment in PP&E
Stock buybacks (TTM)
$75M
share count reduction
Stock-based comp (TTM)
$684M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$8.90B
everything owned
Total liabilities
$1.41B
everything owed
Stockholders' equity
$7.39B
shareholder claim
Net debt
$-1.42B
Net cash position ($1.42B)

Recent performance · 28 quarters

Revenue↑+70.0% +$579M
$1.41B
Net Income↑+670.4% +$530M
$609M
Free Cash Flow↑+67.1% +$307M
$764M
Operating Margin↑+39.6pts
40.9%

Drill down